IDEAYA Biosciences, Inc.

NASDAQ:IDYA

25.61 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income -112.961-58.655-49.762-34.495-41.975-34.346-11.862
Depreciation & Amortization 4.0082.1011.7251.3811.2450.8860.391
Deferred Income Tax 00000-0.873-0.027
Stock Based Compensation 18.48911.6298.2373.6092.1680.950.136
Change In Working Capital -13.207-41.555-17.81384.406-0.2841.6541.564
Accounts Receivables 0.1930.8920.774-1.877000
Inventory 003.7882.285000
Accounts Payables 2.6351.8641.1660.225-0.1950.3220.254
Other Working Capital -16.035-44.311-23.54183.773-0.0891.3321.31
Other Non Cash Items -11.553-0.6951.8340.562-0.4674.109-2.426
Operating Cash Flow -115.224-87.175-55.77955.463-39.313-27.62-12.224
Investing Activities:
Investments In Property Plant And Equipment -2.368-3.443-2.644-0.493-1.353-1.708-1.757
Acquisitions Net 033.40467.022-0.018-0.00800
Purchases Of Investments -595.98-255.808-314.996-242.314-88.004-133.301-13.47
Sales Maturities Of Investments 439.892225.847247.97496.56491.62271.836.3
Other Investing Activites 0-33.404-67.0220.0180.008-61.471-7.17
Investing Cash Flow -158.456-33.404-69.666-146.2432.265-63.179-8.927
Financing Activities:
Debt Repayment 0000000
Common Stock Issued 309.76394.962143.253127.23450.321105.37817.49
Common Stock Repurchased 0000000
Dividends Paid 0000000
Other Financing Activities 52.9542.2032.2011.5160.289105.37817.49
Financing Cash Flow 362.71797.165145.454128.7550.61105.37817.49
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash 89.037-23.41420.00937.9713.56214.579-3.661
Cash At End Of Period 157.77568.73892.15272.14334.17320.6116.032